Author: Vitreoretinal Consultants

Retinal Tears vs. Retinal Detachments: Understanding the Difference

Both retinal tears and retinal detachments are serious eye conditions that require prompt medical attention. Regular eye examinations play a pivotal role in the early detection of retinal issues.

Congratulations: Dr. Ferrone & Dr. Lin Receive the 2023 JVRD Contributor Award

Managing Dry AMD: Tips for Enhancing Vision and Slowing Progression

Did you know that there is a wide range of things that you can do to preserve your vision and potentially slow the progression of dry age-related macular degeneration (AMD)?

Dr. Albert Li’s Life-Saving Care Featured in ASRS Article

A recent article published on the American Society of Retina Specialists (ASRS) website spotlighted the story of how a routine eye exam ended up saving a patient’s life, thanks to the efforts of Vitreoretinal Consultants of NY’s very own Dr. Albert Li.

Watch: Diabetic Retinopathy Animated Video

Did you know that diabetic retinopathy is the leading cause of blindness in American adults? Watch this short, eye-catching animated video to learn about diabetic retinopathy.

From Light to Sight: A Journey into the Retina’s Anatomy and Structure

When you look at an image, you're engaging in a sophisticated operation referred to as visual processing. This intricate procedure depends on the retina, which constitutes a delicate layer of photosensitive tissue.

Exploring the Link Between Smoking and AMD: Facts and Risks

Not only do smokers have a higher likelihood of AMD development, but the more you smoke, the higher your risks.

Living with Retinitis Pigmentosa: Coping Strategies and Support Resources

Although having retinitis pigmentosa can pose a daily struggle for many people with the disorder, there are many services and resources available for people living with RP and their family members.

Award-Winning Retina Specialist Joins Leading Retina Practice in New York

Jeffrey C. Paccione, MD is now part of Vitreoretinal Consultants of NY

The First Treatment for Geographic Atrophy Is Now Available

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking medical breakthrough for people with geographic atrophy (GA) -- Syfovre™ is the first and only treatment for GA.